3 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow GERD: new trials by email Literature Review of GERD trials Research Report on GERD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects CKD-382, D860, D027 - GERD | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 42 | 2021-10-07 | 2021-11-04 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis | Phase 1 / Phase 2 | Unknown | All Natural Medicine Clinic, LLC | 2000 | 2021-03-01 | 2021-05-26 |
| A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects CKD-382(formulation I), CKD-382(formulation II), D026 - GERD | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 48 | 2020-09-25 | 2021-01-11 |
Gastroesophageal Reflux (3) · Ageusia (1) · Anosmia (1) · Anxiety Disorders (1) · Arthritis, Reactive (1) · Bipolar Disorder (1) · COVID-19 stress syndrome (1) · Depression (1) · Glomerulonephritis (1) · Guillain-Barre Syndrome (1) · Heartburn (1) · Hepatitis (1) · Infections (1) · Panic Disorder (1) · Post-Infectious Disorders (1)
Deglutition Disorders (3) · Digestive System Diseases (3) · Esophageal Diseases (3) · Esophageal Motility Disorders (3) · Gastrointestinal Diseases (3) · Arthritis (1) · Arthritis, Infectious (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Behavior (1) · Behavioral Symptoms (1) · Bipolar and Related Disorders (1) · Bone Diseases (1) · Chronic Disease (1) · Demyelinating Diseases (1)
Chong Kun Dang Pharmaceutical (2) · All Natural Medicine Clinic, LLC (1)
South Korea (2) · United States (1)
Wanzhu Hou, CMD (1)